標(biāo)題: Titlebook: Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy; Rajni A. Sethi,Igor J. Barani,Mack Roach III Book [打印本頁] 作者: Hermit 時(shí)間: 2025-3-21 16:05
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy影響因子(影響力)
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy影響因子(影響力)學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy網(wǎng)絡(luò)公開度
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy被引頻次
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy被引頻次學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy年度引用
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy年度引用學(xué)科排名
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy讀者反饋
書目名稱Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy讀者反饋學(xué)科排名
作者: Cpap155 時(shí)間: 2025-3-21 23:57 作者: Nibble 時(shí)間: 2025-3-22 04:27
Spinetting of longer life expectancy, oligometastatic disease, radioresistant histologies, and following surgery. In certain cases, early data suggest that stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Optimal dose and fractiona作者: Pessary 時(shí)間: 2025-3-22 05:23 作者: jovial 時(shí)間: 2025-3-22 11:31 作者: Supplement 時(shí)間: 2025-3-22 14:41 作者: isotope 時(shí)間: 2025-3-22 20:25 作者: antipsychotic 時(shí)間: 2025-3-22 22:35
Extracranial Oligometastasesotherapy or other metastasis-directed therapies, which can provide durable local control and potentially contribute to long-term survival. The aim of this chapter is to present the concepts of the oligometastatic state and summarize the highest quality available literature for oligometastasis-direct作者: 慢慢沖刷 時(shí)間: 2025-3-23 04:53 作者: 苦笑 時(shí)間: 2025-3-23 05:49
Alexander Naumann,Heinz Pfeiffery but also for image guidance. The development of newer techniques requires more rigorous quality assurance procedures. This chapter provides updates on the most recent advancements in the use of stereotactic treatments, including image guidance, quality assurance, and an updated literature review.作者: BARB 時(shí)間: 2025-3-23 11:43 作者: 要控制 時(shí)間: 2025-3-23 16:22 作者: Orchiectomy 時(shí)間: 2025-3-23 19:17
https://doi.org/10.1007/978-3-663-07522-6supported by early results of several randomized trials (RTOG 0938, HYPO-RT-PC, PACE-B) and meta-analyses of prospective trials (Jackson et al., Int J Radiat Oncol Biol Phys 104(4):778–89, 2019; Cushman et al., Oncotarget 10(54):5660–8, 2019) providing supportive data. This chapter summarizes practi作者: acrimony 時(shí)間: 2025-3-24 00:49
Zusammenfassung der Ergebnisse,ological malignancies treated with definitive radiation, where it has demonstrated an overall survival benefit. Stereotactic body radiotherapy (SBRT) has been explored for the treatment of patients who are unable to have brachytherapy procedures, have persistent disease after definitive treatment, d作者: 招募 時(shí)間: 2025-3-24 03:24 作者: MELD 時(shí)間: 2025-3-24 06:48 作者: 標(biāo)準(zhǔn) 時(shí)間: 2025-3-24 10:47 作者: 深陷 時(shí)間: 2025-3-24 18:36 作者: 詞匯表 時(shí)間: 2025-3-24 19:09
Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy978-3-031-33156-5作者: pellagra 時(shí)間: 2025-3-25 00:08 作者: contrast-medium 時(shí)間: 2025-3-25 03:56
Alexander Naumann,Heinz Pfeiffery but also for image guidance. The development of newer techniques requires more rigorous quality assurance procedures. This chapter provides updates on the most recent advancements in the use of stereotactic treatments, including image guidance, quality assurance, and an updated literature review.作者: 有毒 時(shí)間: 2025-3-25 07:47 作者: 引水渠 時(shí)間: 2025-3-25 14:00 作者: corn732 時(shí)間: 2025-3-25 17:34 作者: Concrete 時(shí)間: 2025-3-25 21:48 作者: Pathogen 時(shí)間: 2025-3-26 01:58 作者: biosphere 時(shí)間: 2025-3-26 05:25
Head and NeckThe most common applications of SBRT in head and neck malignancies are for recurrent/metastatic disease. At present, SBRT has no widely accepted role in the definitive treatment of newly diagnosed, nonmetastatic head and neck cancer.作者: Pericarditis 時(shí)間: 2025-3-26 11:19 作者: 巨頭 時(shí)間: 2025-3-26 14:44 作者: 煉油廠 時(shí)間: 2025-3-26 20:12 作者: Perigee 時(shí)間: 2025-3-27 00:40 作者: NAG 時(shí)間: 2025-3-27 03:53 作者: legacy 時(shí)間: 2025-3-27 08:45
Book 2023Latest editionuding the history and development of these modalities, the biologic rationale for these technologies, typical practices, and reported results. Developed as a companion to .Handbook of Evidence-Based Radiation Oncology., edited by Eric Hansen and Mack Roach, III, it is organized by disease site and p作者: 思考而得 時(shí)間: 2025-3-27 09:40 作者: 營養(yǎng) 時(shí)間: 2025-3-27 17:20 作者: boisterous 時(shí)間: 2025-3-27 18:23 作者: ethereal 時(shí)間: 2025-3-27 23:33
Zusammenfassung der Ergebnisse,evelop pelvic or distant recurrences, or present with oligometastatic disease. This chapter explores treatment indications, technique, and management of toxicity and reviews published literature regarding SBRT for gynecologic malignancies.作者: OFF 時(shí)間: 2025-3-28 03:49
Genitourinary Sitescal aspects of SBRT in definitive management of clinically localized prostate cancer, and emerging evidence for the role of SBRT in the setting of oligometastatic prostate cancer, as well as its role in renal cell and adrenal tumors.作者: 發(fā)酵 時(shí)間: 2025-3-28 10:16
Gynecologic Sitesevelop pelvic or distant recurrences, or present with oligometastatic disease. This chapter explores treatment indications, technique, and management of toxicity and reviews published literature regarding SBRT for gynecologic malignancies.作者: 鞠躬 時(shí)間: 2025-3-28 11:29 作者: Culmination 時(shí)間: 2025-3-28 15:10 作者: 負(fù)擔(dān) 時(shí)間: 2025-3-28 19:28
Peter Ramu,Mathis Grenacher,Bruno Thürlimann stereotactic outcomes are superior to conventionally fractionated strategies for both primary and metastatic tumors alike. Optimal dose and fractionation, dose-limiting toxicities, and treatment precision are ongoing areas of controversy and investigation.作者: FLUSH 時(shí)間: 2025-3-29 01:44
Introduction to Stereotactic Radiosurgery and Stereotactic Body Radiotherapy,ong with the development of megavoltage treatment machines, imaging-based treatment planning, and intensity-modulated radiation therapy. This chapter outlines the historical foundations and development of SRS and SBRT technologies.作者: Oligarchy 時(shí)間: 2025-3-29 04:42 作者: 恃強(qiáng)凌弱 時(shí)間: 2025-3-29 08:59
https://doi.org/10.1007/978-3-663-14270-6pecially for lesions less suited to resection or radiofrequency ablation (RFA). Retrospective studies have demonstrated excellent local control of metastases in the lung, spine, liver, and brain, with some series suggesting a survival benefit in patients with oligometastatic disease in particular.作者: Pde5-Inhibitors 時(shí)間: 2025-3-29 14:15 作者: Repatriate 時(shí)間: 2025-3-29 15:37
